Roman Kaliszan

Author PubWeight™ 33.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prediction of peptide retention at different HPLC conditions from multiple linear regression models. J Proteome Res 2005 0.93
2 Comparative characteristics of HPLC columns based on quantitative structure-retention relationships (QSRR) and hydrophobic-subtraction model. J Chromatogr A 2005 0.91
3 Reversed-phase TLC and HPLC retention data in correlation studies with in silico molecular descriptors and druglikeness properties of newly synthesized anticonvulsant succinimide derivatives. Mol Pharm 2011 0.89
4 Simultaneous determination of pKa and lipophilicity by gradient RP HPLC. Anal Chem 2006 0.87
5 Predictions of peptides' retention times in reversed-phase liquid chromatography as a new supportive tool to improve protein identification in proteomics. Proteomics 2009 0.86
6 Determination of pKa by pH gradient reversed-phase HPLC. Anal Chem 2004 0.86
7 Electrochemical impedance spectroscopy for study of amyloid beta-peptide interactions with (-) nicotine ditartrate and (-) cotinine. Biosens Bioelectron 2006 0.86
8 Comparative evaluation of high-performance liquid chromatography stationary phases used for the separation of peptides in terms of quantitative structure-retention relationships. J Chromatogr A 2007 0.85
9 Artificial neural network analysis for evaluation of peptide MS/MS spectra in proteomics. Anal Chem 2004 0.83
10 The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods. Anal Bioanal Chem 2011 0.83
11 Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers. J Chromatogr A 2013 0.83
12 Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. Curr Med Chem 2003 0.82
13 The application of gradient reversed-phase high-performance liquid chromatography to the pK(a) and log k(w) determination of polyprotic analytes. J Chromatogr A 2008 0.82
14 Quantitative structure-retention relationships in affinity high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.81
15 Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery. Pharmacol Rep 2012 0.81
16 Development and validation of urinary nucleosides and creatinine assay by capillary electrophoresis with solid phase extraction. J Pharm Biomed Anal 2007 0.80
17 Association constants of pyridine and piperidine alkaloids to amyloid beta peptide determined by electrochemical impedance spectroscopy. Curr Alzheimer Res 2010 0.80
18 pH/organic solvent double-gradient reversed-phase HPLC. Anal Chem 2005 0.80
19 The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats. Biopharm Drug Dispos 2014 0.80
20 Micellar liquid chromatography for lipophilicity determination of new biologically active 1,3-purinodiones. J Sep Sci 2010 0.79
21 Predictive approaches to gradient retention based on analyte structural descriptors from calculation chemistry. J Chromatogr A 2003 0.79
22 New supervised alignment method as a preprocessing tool for chromatographic data in metabolomic studies. J Chromatogr A 2012 0.79
23 Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis. J Pharm Biomed Anal 2010 0.79
24 Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques. Electrophoresis 2010 0.79
25 Combination of linear solvent strength model and quantitative structure-retention relationships as a comprehensive procedure of approximate prediction of retention in gradient liquid chromatography. J Chromatogr A 2002 0.78
26 Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds. Anal Chim Acta 2013 0.78
27 Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children. Pharmacol Rep 2013 0.78
28 pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides. Talanta 2007 0.78
29 Efficient recovery of electrophoretic profiles of nucleoside metabolites from urine samples by multivariate curve resolution. Electrophoresis 2009 0.78
30 Correctness of protein identifications of Bacillus subtilis proteome with the indication on potential false positive peptides supported by predictions of their retention times. J Biomed Biotechnol 2009 0.78
31 Verification of the exponential model of body temperature decrease after death in pigs. Exp Physiol 2005 0.77
32 Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes. Am J Hypertens 2013 0.77
33 Chromatographic retention parameters in correlation analysis with in silico biological descriptors of a novel series of N-phenyl-3-methyl succinimide derivatives. J Pharm Biomed Anal 2012 0.77
34 Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients. Bioanalysis 2012 0.77
35 Evaluation of the silanol-suppressing potency of ionic liquids. J Sep Sci 2006 0.77
36 Evaluation of a generalized use of the log Sum(k+1)AA descriptor in a QSRR model to predict peptide retention on RPLC systems. J Sep Sci 2009 0.77
37 Mydriasis model in rats as a simple system to evaluate α2-adrenergic activity of the imidazol(in)e compounds. Pharmacol Rep 2013 0.76
38 Imidazoline receptors in relaxation of acetylcholine-constricted isolated rat jejunum. Pharmacol Rep 2006 0.76
39 Quantitative structure-activity relationships study of a series of imidazole derivatives as potential new antifungal drugs. Acta Pol Pharm 2002 0.76
40 Human red blood cells targeted metabolome analysis of glycolysis cycle metabolites by capillary electrophoresis using an indirect photometric detection method. J Pharm Biomed Anal 2005 0.76
41 The application of 19F magnetic resonance ex vivo imaging of three-dimensional cultured breast cancer cells to study the effect of delta-tocopherol. Anal Biochem 2009 0.76
42 Determination of ascorbic acid and its degradation products by high-performance liquid chromatography-triple quadrupole mass spectrometry. Electrophoresis 2014 0.76
43 Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands. J Pharm Pharm Sci 2013 0.76
44 Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery. J Pharmacokinet Pharmacodyn 2015 0.75
45 19F MRI of 3D CEM cells to study the effects of tocopherols and tocotrienols. J Pharm Biomed Anal 2010 0.75
46 A new pH/organic modifier gradient RP HPLC method for convenient determination of lipophilicity and acidity of drugs as applied to established imidazoline agents. Eur J Pharm Sci 2012 0.75
47 Retention time and peak width in the combined pH/organic modifier gradient high performance liquid chromatography. J Chromatogr A 2010 0.75
48 Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry. J Pharm Biomed Anal 2012 0.75
49 Using bioanalysis for cancer diagnosis and prognosis. Bioanalysis 2014 0.75
50 Magnetic beads method for determination of binding of drugs to melanin. J Chromatogr A 2010 0.75
51 Combined pH/organic solvent gradient HPLC in analysis of forensic material. J Pharm Biomed Anal 2005 0.75
52 Influence of pH on retention in linear organic modifier gradient RP HPLC. Anal Chem 2008 0.75
53 Behavior of peptides and computer-assisted optimization of peptides separations in a normal-phase thin-layer chromatography system with and without the addition of ionic liquid in the eluent. Biomed Chromatogr 2005 0.75
54 Ionic liquids as mobile phase additives for feasible assay of naphazoline in pharmaceutical formulation by HPTLC-UV-densitometric method. J Chromatogr Sci 2012 0.75
55 Quantitative structure-retention relationships in comparative studies of behavior of stationary phases under high-performance liquid chromatography and capillary electrochromatography conditions. J Chromatogr A 2002 0.75
56 pH Gradient as a tool for the separation of ionizable analytes in reversed-phase high-performance chromatography. Anal Chem 2010 0.75
57 High-throughput evaluation of lipophilicity and acidity by new gradient HPLC methods. Comb Chem High Throughput Screen 2004 0.75
58 Development and validation of UHPLC method for the determination of cyclosporine A in biological samples. Biomed Chromatogr 2014 0.75
59 pH-Gradient Liquid Chromatography: Fundamentals and Examples. J AOAC Int 2017 0.75
60 Artificial neural networks for prediction of antibacterial activity in series of imidazole derivatives. Comb Chem High Throughput Screen 2004 0.75
61 Advanced assessment of the endogenous hormone level as a potential biomarker of the urogenital tract cancer. Comb Chem High Throughput Screen 2013 0.75
62 Evaluation of different warping methods for the analysis of CE profiles of urinary nucleosides. Electrophoresis 2007 0.75
63 Reversed- and normal-phase liquid chromatography in quantitative structure retention-property relationships of newly synthesized seco-androstene derivatives. J Pharm Biomed Anal 2013 0.75
64 Separation of nicotinic acid and its structural isomers using 1-ethyl-3-methylimidazolium ionic liquid as a buffer additive by capillary electrophoresis. J Pharm Biomed Anal 2005 0.75